First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites.
about
Plasticity of the Leishmania genome leading to gene copy number variations and drug resistanceReactivation of flagellar motility in demembranated Leishmania reveals role of cAMP in flagellar wave reversal to ciliary waveformA CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastidsCRISPR/Cas9-Induced Disruption of Paraflagellar Rod Protein 1 and 2 Genes in Trypanosoma cruzi Reveals Their Role in Flagellar Attachment.CRISPR/Cas9-The ultimate weapon to battle infectious diseases?EuPaGDT: a web tool tailored to design CRISPR guide RNAs for eukaryotic pathogens.NADH dehydrogenase of Trypanosoma brucei is important for efficient acetate production in bloodstream forms.CRISPR-Cas9 technology and its application in haematological disorders.Genome Editing by CRISPR/Cas9: A Game Change in the Genetic Manipulation of Protists.Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need.Reexamining opportunities for therapeutic protein production in eukaryotic microorganisms.Shape, form, function and Leishmania pathogenicity: from textbook descriptions to biological understanding.Taming Parasites by Tailoring Them.CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.Optimized CRISPR-Cas9 Genome Editing for Leishmania and Its Use To Target a Multigene Family, Induce Chromosomal Translocation, and Study DNA Break Repair Mechanisms.Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.A single-cysteine mutant and chimeras of essential Leishmania Erv can complement the loss of Erv1 but not of Mia40 in yeast.Genome editing technologies to fight infectious diseases.Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.Characterisation of Casein Kinase 1.1 in Leishmania donovani Using the CRISPR Cas9 Toolkit.CRISPR/Cas9-mediated gene modification and gene knock out in the human-infective parasite Trichomonas vaginalis.CRISPR/Cas9 in Leishmania mexicana: A case study of LmxBTN1.Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR/Cas9 functionality for rapid in vivo localisation and phenotyping.The CRISPR/Cas9 system sheds new lights on the biology of protozoan parasites.Joining forces: first application of a rapamycin-induced dimerizable Cre system for conditional null mutant analysis in Leishmania.Inducible high-efficiency CRISPR-Cas9-targeted gene editing and precision base editing in African trypanosomes.
P2860
Q28074697-36D8B71F-989F-4165-B99D-F846F73AC284Q30828816-8EE7DFC7-B5AF-4CB3-BC64-378A1E32ED63Q33748131-18E9121A-65BC-4DFB-AF9C-030AB3237928Q35883736-55401CE5-C842-4A53-A50D-3C04050C98C9Q36196813-7D7E7A9A-BFAD-468B-A61F-242996784C05Q36324791-875289BE-E7B9-4CA2-A8FB-5937E667D695Q37579504-7A6AC73C-12D8-47F3-84BB-7A04FAAABC60Q38822073-D21951F3-A370-4503-B26C-E9F3BBA62FD6Q38868478-429F3FBD-4111-41C7-9811-B68FD85DF7B4Q39003990-538C730A-4394-462A-B800-594D7639600FQ39422292-A5FE2BCF-36B9-477B-BA58-411466C69302Q40048183-06FCEF7C-DB99-468D-B682-52E6D33A5BEAQ40125529-A7FBF91C-106D-4A03-B5FC-05E091A07F40Q41096535-2EF2DD9C-52C5-46F1-A2F2-FD81AD828C65Q42329832-957068E5-3D05-44FD-AA41-EDFFFE45A2DBQ47162699-49CB8540-8C98-458E-B46C-43CDAFFB63D2Q47224216-652ECF0E-3E8E-4BAD-A855-A5B6F59A04A9Q47392998-BFB41E24-EC86-4C01-AD22-964E651514E7Q47702679-9DE3D706-814C-423C-8FA3-6173C72B7CADQ48246352-B9E675BE-292F-49E2-8249-35478D9521DBQ48267186-E39588D0-4EFC-48CC-8E97-8ED7B4CAA308Q50041667-5D50F0EA-7C78-4186-96C3-2F0783B198C5Q52334618-A5E5114E-C1EE-4220-A8C9-A25362AFE073Q52431375-7B36B246-B052-4A23-A7D7-DC6511A95310Q55026574-263BC0D7-3087-4C0A-BD98-0133A235A404Q55289800-CAFFC767-5D7E-4EA7-B24A-D79A2589A853
P2860
First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites.
@en
First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites.
@nl
type
label
First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites.
@en
First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites.
@nl
prefLabel
First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites.
@en
First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites.
@nl
P2093
P2860
P50
P356
P1476
First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites.
@en
P2093
Artur Scherf
Lauriane Sollelis
Lucien Crobu
Rafael Miyazawa Martins
Yvon Sterkers
P2860
P304
P356
10.1111/CMI.12456
P577
2015-05-04T00:00:00Z